 SHARE 
|
|
Dave graduated in 1978 from the Northern Alberta Institute of Technology (NAIT) as an engineering technologist. He later worked in the Faculty of Dentistry at the University of Alberta designing TMJ Dysfunction diagnostic equipment and research facilities under the direction of Dr. Norman Thomas (a leading TMJ researcher at the time). Dave organized research projects, taught basic physiology and an advanced TMJ diagnostics course. Dave had noted anxiety issues in many patients suffering with TMJ dysfunction, which lead him to study biofeedback under Dr. George Fitzsimmons.
In 1981, Dave incorporated Comptronic Devices Limited. Dave's first research device was the "silent-period" detector. This was a timed electromyography (EMG) device that could measure the length of time muscular inhibition occurred when a person bit his/her teeth together. This technique allowed a dentist to determine the degree to which TMJ-related pain was related to malocclusion or whether it was of emotional origin.
Dave's first commercial devices were the Neuropulse II, a two-channel slow-speed transcutaneous electrical nerve stimulation (TENS) device used to relax tense jaw, neck and back muscles, and the Bruxstopper, which was a small device used to detect teeth-grinding in those asleep, to inform them to stop bruxing.
In 1984, Dave designed his first BWE device, - the DAVID1 (Digital Audio/Visual Integration Device), which was used to help performing arts students at the University of Alberta overcome stage fright.
Dave later coined the term "audio-visual entrainment" (AVE) to better reflect the type of brainwave entrainment the DAVID1 produced. In 2002, David changed the name from Comptronic Devices Limited to Mind Alive Inc. to better reflect the direction his company had taken, following the development of the DAVID1.
Dave has also marketed the "Bioscan" line of biofeedback devices, which measured electro-dermal response (EDR) and brain waves (EEG). Dave also designs cranio-electro stimulation (CES), transcranial DC stimulation and biofeedback devices.
Through his company, Mind Alive Inc., Dave has been researching and refining AVE technology, specifically for use in relaxation, insomnia, anxiety, depression, premenstrual syndrome (PMS), attention deficit disorder (ADD), fibromyalgia (FM), seasonal affective disorder (SAD), pain, cognitive decline, risk-of-falling in seniors, reduced worry and improved grades in college students, and as a performance enhancer in athletes. Dave continues to conduct research and design new products relating to personal growth and wellness. Dave presents at many professional association conferences and provides training throughout North America and Europe. Professional conferences he has lectured at include:
Association of Applied Psychophysiology and Biofeedback,
Intl. Society of Neurofeedback and Research,
American College for the Advancement of Medicine, and the
College of Syntonic Optometry.
Futurehealth Member for 757 week(s) and 1 day(s)
Content Pageviews (Total/Last Month) - Article Pageviews (3,770/19) - Quicklink Pageviews (None/None) - Diary Pageviews (None/None) - Poll Pageviews (None/None)
1 Articles, 0 Quick Links, 0 Comments, 0 Diaries, 0 Polls
Articles Listed By Date
List By Popularity
List By Popularity
SHARE
Sunday, August 15, 2010
The Use of Audio-Visual Entrainment for the Treatment of Attention Deficit/Hyperactivity Disorder (3770 views) A review of the research regarding audio-visual entrainment for the treatment of ADD/ADHD.
Sunday, August 15, 2010The Use of Audio-Visual Entrainment for the Treatment of Attention Deficit/Hyperactivity Disorder (3770 views) A review of the research regarding audio-visual entrainment for the treatment of ADD/ADHD.
